These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20336371)

  • 1. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study.
    Ting KN; Stratton-Powell DM; Anderson C
    Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight.
    Elkalmi RM; Hassali MA; Ibrahim MI; Jamshed SQ; Al-Lela OQ
    J Patient Saf; 2014 Jun; 10(2):81-7. PubMed ID: 24618640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
    Li R; Curtain C; Bereznicki L; Zaidi STR
    Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
    Barnes J; Butler R
    Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the intention of community pharmacists to report adverse drug reactions to regulatory authority in Malaysia: application of the theory of planned behaviour.
    Raghvan HPN; Fatokun O
    Int J Pharm Pract; 2021 Oct; 29(5):435-442. PubMed ID: 34244775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
    Krska J
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
    Zimmermann A; Gaworska-Krzeminska A; Flis A
    Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.
    Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB
    Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring community pharmacists' views on generic medicines: a nationwide study from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Int J Clin Pharm; 2011 Feb; 33(1):124-31. PubMed ID: 21365404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
    Vessal G; Mardani Z; Mollai M
    Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
    Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
    Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia.
    Selvaraj A; Redzuan AM; Hatah E
    Int J Clin Pharm; 2020 Apr; 42(2):777-785. PubMed ID: 32006142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
    Lee KK; Chan TY; Raymond K; Critchley JA
    Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.